Literature DB >> 22290614

Assessing the enrichment performance in targeted resequencing experiments.

Peter Frommolt1, Ali T Abdallah, Janine Altmüller, Susanne Motameny, Holger Thiele, Christian Becker, Kathryn Stemshorn, Matthias Fischer, Tobias Freilinger, Peter Nürnberg.   

Abstract

Target enrichment strategies are a very common approach to sequence a predefined part of an individual's genome using second-generation sequencing technologies. While highly dependent on the technology and the target sequences selected, the performance of the various assays is also variable between samples and is influenced by the way how the libraries are handled in the laboratory. Here, we show how to find detailed information about the enrichment performance using a novel software package called NGSrich, which we developed as a part of a whole-exome resequencing pipeline in a medium-sized genomics center. Our software is suitable for high-throughput use and the results can be shared using HTML and a web server. Finally, we have sequenced exome-enriched DNA libraries of 18 human individuals using three different enrichment products and used our new software for a comparative analysis of their performance.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22290614     DOI: 10.1002/humu.22036

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  Advancing genetic testing for deafness with genomic technology.

Authors:  A Eliot Shearer; E Ann Black-Ziegelbein; Michael S Hildebrand; Robert W Eppsteiner; Harini Ravi; Swati Joshi; Angelica C Guiffre; Christina M Sloan; Scott Happe; Susanna D Howard; Barbara Novak; Adam P Deluca; Kyle R Taylor; Todd E Scheetz; Terry A Braun; Thomas L Casavant; William J Kimberling; Emily M Leproust; Richard J H Smith
Journal:  J Med Genet       Date:  2013-06-26       Impact factor: 6.318

3.  Novel PTPRQ mutations identified in three congenital hearing loss patients with various types of hearing loss.

Authors:  Naoko Sakuma; Hideaki Moteki; Hela Azaiez; Kevin T Booth; Masahiro Takahashi; Yasuhiro Arai; A Eliot Shearer; Christina M Sloan; Shin-Ya Nishio; Diana L Kolbe; Satoshi Iwasaki; Nobuhiko Oridate; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-18       Impact factor: 1.547

4.  Hearing loss caused by a P2RX2 mutation identified in a MELAS family with a coexisting mitochondrial 3243AG mutation.

Authors:  Hideaki Moteki; Hela Azaiez; Kevin T Booth; Mitsuru Hattori; Ai Sato; Yoshihiko Sato; Mitsuo Motobayashi; Christina M Sloan; Diana L Kolbe; A Eliot Shearer; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-18       Impact factor: 1.547

5.  USH2 caused by GPR98 mutation diagnosed by massively parallel sequencing in advance of the occurrence of visual symptoms.

Authors:  Hideaki Moteki; Hidekane Yoshimura; Hela Azaiez; Kevin T Booth; A Eliot Shearer; Christina M Sloan; Diana L Kolbe; Toshinori Murata; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-05       Impact factor: 1.547

6.  Mutations in LOXHD1 gene cause various types and severities of hearing loss.

Authors:  Kentaro Mori; Hideaki Moteki; Yumiko Kobayashi; Hela Azaiez; Kevin T Booth; Shin-Ya Nishio; Hiroaki Sato; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-19       Impact factor: 1.547

7.  De novo mutation in X-linked hearing loss-associated POU3F4 in a sporadic case of congenital hearing loss.

Authors:  Hideaki Moteki; A Eliot Shearer; Shuji Izumi; Yamato Kubota; Hela Azaiez; Kevin T Booth; Christina M Sloan; Diana L Kolbe; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-19       Impact factor: 1.547

8.  The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.

Authors:  Ryo Maruoka; Toshiki Takenouchi; Chiharu Torii; Atsushi Shimizu; Kumiko Misu; Koichiro Higasa; Fumihiko Matsuda; Arihito Ota; Katsumi Tanito; Akira Kuramochi; Yoshimi Arima; Fujio Otsuka; Yuichi Yoshida; Keiji Moriyama; Michihito Niimura; Hideyuki Saya; Kenjiro Kosaki
Journal:  Genet Test Mol Biomarkers       Date:  2014-10-17

9.  Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.

Authors:  Amos J Simon; Atar Lev; Marta Jeison; Zvi U Borochowitz; David Korn; Yaniv Lerenthal; Raz Somech
Journal:  J Clin Immunol       Date:  2013-11-07       Impact factor: 8.317

10.  Comprehensive genetic testing with ethnic-specific filtering by allele frequency in a Japanese hearing-loss population.

Authors:  H Moteki; H Azaiez; K T Booth; A E Shearer; C M Sloan; D L Kolbe; S Nishio; M Hattori; S Usami; R J H Smith
Journal:  Clin Genet       Date:  2015-10-06       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.